Latent Autoimmune Diabetes in Adults (LADA) in Recent Clinical Practice
DOI:
https://doi.org/10.17140/DROJ-5-e014Abstract
Diabetic patients have been increasing and this tendency has become a medical and social problem worldwide.1 There are
some types of diabetes, in which the prevalence of type 2 diabetes mellitus (T2DM) has been higher without requiring insulin treatment. On the other hand, type 1 diabetes mellitus (T1DM) has acute onset due to virus infection. Under such circumstances, there is a disease that has been clinically important in recent years. It is Latent autoimmune diabetes in adults (LADA).
References
Kowall B, Rathmann W, Bongaerts B, et al. Incidence rates of type 2 diabetes in people with impaired fasting glucose (ADA vs. WHO Criteria) and impaired glucose tolerance: Results from an older population (KORA S4/F4/FF4 Study). Diabetes Care. 2019; 42(2): e18-e20. doi: 10.2337/dc18-1473
Kawasaki E, Nakamura K, Kuriya G, et al. Differences in the hu-moral autoreactivity to zinc transporter 8 between childhood- and adult-onset type 1 diabetes in Japanese patients. Clin Immunol. 2011; 138(2): 146-153. doi: 10.1016/j.clim.2010.10.007
Wenzlau JM, Juhl K, Yu L, et al. The cation efflux transporter ZnT8 (Slc30A8) is a major autoantigen in human type 1 diabe-tes. Proc Natl Acad Sci U S A. 2007; 104(43): 17040-17045. doi: 10.1073/pnas.0705894104
Zhou Z, Xiang Y, Ji L, et al. Frequency, immunogenetics, and clinical characteristics of latent autoimmune diabetes in China (LADA China study): A nationwide, multicenter, clinic-based cross-sectional study. Diabetes. 2013; 62(2): 543-550 doi: 10.2337/ db12-0207
Kobayashi T, Tamemoto K, Nakanishi K, et al. Immunogenetic and clinical characterization of slowly progressive IDDM. Diabetes Care. 1993; 16(5): 780-788.
Buzzetti R, Di Pietro S, Giaccari A, et al. High titer of autoanti-bodies to GAD identifies a specific phenotype of adult-onset auto-immune diabetes. Diabetes Care 2007; 30(4): 932-938. doi: 10.2337/ dc06-1696
Leslie RD, Palmer J, Schloot NC, et al. Diabetes at the cross-roads: Relevance of disease classification to pathophysiology and treatment. Diabetologia. 2016; 59(1): 13-20. doi: 10.1007/s00125- 015-3789-z
Awata T, Shimada A, Maruyama T, et al. Possible long-term ef-ficacy of sitagliptin, a dipeptidyl peptidase-4 inhibitor, for slowly progressive type 1 diabetes (SPIDDM) in the stage of non–in-sulin-dependency: An open-label randomized controlled pilot trial (SPAN-S). Diabetes Ther. 2017; 8(5):1123-1134. doi: 10.1007/ s13300-017-0299-7
Aida K, Fukui T, Jimbo E, et al. Distinct Inflammatory Chang-es of the pancreas of slowly progressive insulin-dependent (Type 1) diabetes. Pancreas. 2018; 47(9): 1101-1109. doi: 10.1097/ MPA.0000000000001144
Pieralice S, Pozzilli P. Latent autoimmune diabetes in adults: A Editorial | Volume 5 | Number 1| review on clinical implications and management. Diabetes Metab J. 2018; 42(6): 451-464. doi: 10.4093%2Fdmj.2018.0190
Mishra R, Hodge KM, Cousminer DL, Leslie RD, Grant SFA. A global perspective of latent autoimmune diabetes in adults. Trends Endocrinol Metab. 2018; 29(9): 638-650. doi: 10.1016/j. tem.2018.07.001
Maddaloni E, Lessan N, Al Tikriti A, Buzzetti R, Pozzilli P, Barakat MT. Latent autoimmune diabetes in adults in the United Arab Emirates: Clinical features and factors related to insulin-re-quirement. PLoS One. 2015; 10(8): e0131837. doi: 10.1371/journal. pone.0131837
American Diabetes Association. 2. Classification and diagnosis of diabetes. Diabetes Care. 2015; 38(1): S8-S16. doi: 10.2337/dc15- S005
Hernandez M, Mollo A, Marsal JR, et al. Insulin secretion in patients with latent autoimmune diabetes (LADA): Half way be-tween type 1 and type 2 diabetes: Action LADA 9. BMC Endocr Disord. 2015; 15: 1. doi: 10.1186/1472-6823-15-1
Park Y, Wintergerst KA, Zhou Z. Clinical heterogeneity of type 1 diabetes (T1D) found in Asia. Diabetes Metab Res Rev. 2017; 33(7). doi: 10.1002/dmrr.2907
Buzzetti R, Zampetti S, Maddaloni E. Adult-onset autoim-mune diabetes: Current knowledge and implications for manage-Submit your article to this journal | https://openventio.org/submit-manuscript/ Editorial | Volume 5 | Number 1| Bando H ment. Nat Rev Endocrinol. 2017; 13(11): 674-686. doi: 10.1038/ nrendo.2017.99
Takagi S, Miura J, Hoshina S, Uchigata Y, Babzono T. Asso-ciation of anti-GAD antibody positivity measured by RIA and ELISA with clinical characteristics in patients with type 1 diabetes. Diabetes. 2018; 67(1). doi: 10.2337/db18-1700-P
Hawa MI, Kolb H, Schloot N, et al. Adult-onset autoimmune diabetes in Europe is prevalent with a broad clinical phenotype: Action LADA 7. Diabetes Care. 2013; 36(4): 908-913. doi: 10.2337/ dc12-0931
Buzzetti R, Spoletini M, Zampetti S, et al. Tyrosine phospha-tase-related islet antigen 2(256-760) autoantibodies, the only mark-er of islet autoimmunity that increases by increasing the degree of BMI in obese subjects with type 2 diabetes. Diabetes Care. 2015; 38(3): 513-520. doi: 10.2337/dc14-1638
Rawshani A, Landin-Olsson M, Svensson AM, et al. The inci-dence of diabetes among 0-34 year olds in Sweden: New data and better methods. Diabetologia. 2014; 57(7): 1375-1381. doi: 10.1007/ s00125-014-3225-9
Sachan A, Zaidi G, Sahu RP, Agrawal S, Colman PG, Bhatia E. Low prevalence of latent autoimmune diabetes in adults in northern India. Diabet Med. 2015; 32(6): 810-813. doi: 10.1111/ dme.12644 e6
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All content published in Diabetes Research (DR) is licensed under the Creative Commons Attribution 4.0 International License (CC BY 4.0). This license allows anyone to copy, distribute, transmit, and adapt the work — including for commercial purposes — provided appropriate credit is given to the original author(s) and source.
